EPHA2 and central nervous system cancer: Despite challenges in identifying an ideal target for solid tumours, exploration of new targets such as EphA2 (187, 188), GD2 (194, 195), B7-H2 (196, 197), Chlorotoxin (198) and CD317 (199) in CAR-T therapy of gliomas holds promise for developing combination treatment strategies.